Vierpolders, N/A, Netherlands
Vitreq Bv recalls
1 recall recorded since 2018, most recently on 17 December 2019. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Medical devices
- Recall started
- 17 December 2019
- Terminated
- 9 December 2020
- Reason
- Microscopic tears of the sterile pouch may compromise sterility
- Distribution
- Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- Z-0857-2020, Z-0859-2020, Z-0846-2020, Z-0851-2020, Z-0852-2020, Z-0854-2020, Z-0849-2020, Z-0856-2020, Z-0847-2020, Z-0850-2020, Z-0858-2020, Z-0855-2020 and 4 more
- VitreQ 23G Pick Needles-REF: CN23.D04 GTIN: 8719214221584
- VitreQ 23G Blunt Needles with luer-lock connector-REF: CN23.D05 GTIN: 8719214221621
- (1) VitreQ 23G BF Blunt Needles-BF23.D51 GTIN#: 8719214221126 (2) VitreQ 23G BF Brush Needles-BF23.D52 GTIN#: 8719214221140
- VitreQ 23G VFI Cannula-REF: CN23.D03 GTIN: 8719214221423
- VitreQ 25G VFI Cannula-REF: CN25.D03 GTIN: 8719214221447
- VitreQ 20G VFI Cannula-REF: CN20.D03 GTIN: 8719214221485
- VitreQ 23G PFC Injection Needle- Ref: MD23.D01 GTIN: 8719214221362
- VitreQ 25G Silicone Tipped Cannula-REF: CN25.D01 GTIN: 8719214221522
- and 8 more product lines
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.